OUR PRODUCTS

MOBILE APPS

GENERAL INFO

FATE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Fate Therapeutics (FATE) Earnings Date & Reports

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FATE is expected to report earnings to rise 7.00% to -31 cents per share on October 30

Fate Therapeutics FATE Stock Earnings Reports

Q3'25

Est.

$-0.31

Q2'25

Beat

by $0.05

Q1'25

Beat

by $0.07

Q4'24

Est.

$-0.44

Q3'24

Beat

by $0.02

The last earnings report on August 12 showed earnings per share of -28 cents, beating the estimate of -34 cents. With 2.41M shares outstanding, the current market capitalization sits at 125.71M.

View a ticker or compare two or three

Compare

FATE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For FATE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FATE showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12278 Scripps Summit Drive

Phone

+1 858 875-1800

Employees

220

Web

https://www.fatetherapeutics.com